The Impact of NLRP3 Inflammasome on Osteoblasts and Osteogenic Differentiation: A Literature Review

References

• Ponzetti M, Rucci N. Osteoblast differentiation and signaling: established concepts and emerging topics. Int J Mol Sci. 2021;22(13):6651. doi:10.3390/ijms22136651
   PubMed Web of Science ®Google Scholar
• Chen W, Wu P, Yu F, Luo G, Qing L, Tang J. HIF-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells. 2022;11(22):3552. doi:10.3390/cells11223552
   PubMed Web of Science ®Google Scholar
• Almalki SG, Agrawal DK. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016;92(1–2):41–51. doi:10.1016/j.diff.2016.02.005
   PubMed Web of Science ®Google Scholar
• Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908–923. doi:10.1016/S2213-8587(17)30184-5
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang Y, Wu Y, et al. Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis. Nano Today. 2024;54:102074. doi:10.1016/j.nantod.2023.102074
   Web of Science ®Google Scholar
• Luo X, Wan Q, Cheng L, Xu R. Mechanisms of bone remodeling and therapeutic strategies in chronic apical periodontitis. Front Cell Infect Microbiol. 2022;12:908859. doi:10.3389/fcimb.2022.908859
   PubMed Web of Science ®Google Scholar
• Zhu S, Zhu J, Zhen G, et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Invest. 2019;129(3):1076–1093. doi:10.1172/JCI121561
   PubMed Web of Science ®Google Scholar
• Tamaddon M, Gilja H, Wang L, et al. Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic. Biomate Rransl. 2020;1(1):3–17. doi:10.3877/cma.j.issn.2096-112X.2020.01.002
   PubMedGoogle Scholar
• Zheng G, Zhao Y, Li Z, et al. GLSP and GLSP-derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis. Theranostics. 2023;13(4):1325–1341. doi:10.7150/thno.80250
   PubMed Web of Science ®Google Scholar
• Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol. 2022;18(4):224–240. doi:10.1038/s41581-021-00513-4
   PubMed Web of Science ®Google Scholar
• Pillai ICL, Li S, Romay M, et al. Cardiac fibroblasts adopt osteogenic fates and can be targeted to attenuate pathological heart calcification. Cell Stem Cell. 2017;20(2):218–232.e215. doi:10.1016/j.stem.2016.10.005
   PubMed Web of Science ®Google Scholar
• Yang F, Liu S, Gu Y, et al. MicroRNA-22 promoted osteogenic differentiation of valvular interstitial cells by inhibiting CAB39 expression during aortic valve calcification. Cell Mol Life Sci. 2022;79(3):146. doi:10.1007/s00018-022-04177-6
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Sig Transd Target Therapy. 2021;6(1):128. doi:10.1038/s41392-021-00507-5
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99–109. doi:10.1038/nrmicro2070
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi:10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou F, Feng X, et al. FoxO1/NLRP3 inflammasome promotes age-related alveolar bone resorption. J Dent Res. 2023;102(8):919–928. doi:10.1177/00220345231164104
   PubMed Web of Science ®Google Scholar
• Detzen L, Cheat B, Besbes A, et al. NLRP3 is involved in long bone edification and the maturation of osteogenic cells. J Cell Physiol. 2021;236(6):4455–4469. doi:10.1002/jcp.30162
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang L, Wang Z, et al. Melatonin suppresses estrogen deficiency-induced osteoporosis and promotes osteoblastogenesis by inactivating the NLRP3 inflammasome. Calcified Tissue Int. 2018;103(4):400–410. doi:10.1007/s00223-018-0428-y
   PubMed Web of Science ®Google Scholar
• Behera J, Ison J, Voor MJ, Tyagi N. Exercise-linked skeletal irisin ameliorates diabetes-associated osteoporosis by inhibiting the oxidative damage-dependent miR-150-FNDC5/Pyroptosis axis. Diabetes. 2022;71(12):2777–2792. doi:10.2337/db21-0573
   PubMed Web of Science ®Google Scholar
• Lu J, Xie S, Deng Y, Xie X, Liu Y. Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis. Atherosclerosis. 2022;347:28–38. doi:10.1016/j.atherosclerosis.2022.03.005
   PubMed Web of Science ®Google Scholar
• Pham TH, Kim EN, Trang NM, Jeong GS. Gallic acid induces osteoblast differentiation and alleviates inflammatory response through GPR35/GSK3β/β-catenin signaling pathway in human periodontal ligament cells. J Periodontal Res. 2023;59(1):204–219. doi:10.1111/jre.13208
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell. 2002;10(2):417–426. doi:10.1016/S1097-2765(02)00599-3
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666–671. doi:10.1038/nature15541
   PubMed Web of Science ®Google Scholar
• Christgen S, Kanneganti TD. Inflammasomes and the fine line between defense and disease. Curr Opinion Immunol. 2020;62:39–44. doi:10.1016/j.coi.2019.11.007
   PubMed Web of Science ®Google Scholar
• Bauernfried S, Hornung V. Human NLRP1: from the shadows to center stage. J Exp Med. 2022;219(1). doi:10.1084/jem.20211405
   PubMed Web of Science ®Google Scholar
• Calabrese L, Fiocco Z, Mellett M, et al. Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases. Br J Dermatol. 2024;190(3):305–315. doi:10.1093/bjd/ljad421
   PubMedGoogle Scholar
• Wen J, Xuan B, Liu Y, et al. Updating the NLRC4 inflammasome: from bacterial infections to autoimmunity and cancer. Front Immunol. 2021;12:702527. doi:10.3389/fimmu.2021.702527
   PubMed Web of Science ®Google Scholar
• Duncan JA, Canna SW. The NLRC4 inflammasome. Immunol Rev. 2018;281(1):115–123. doi:10.1111/imr.12607
   PubMed Web of Science ®Google Scholar
• Du L, Wang X, Chen S, Guo X. The AIM2 inflammasome: a novel biomarker and target in cardiovascular disease. Pharmacol Res. 2022;186:106533. doi:10.1016/j.phrs.2022.106533
   PubMed Web of Science ®Google Scholar
• Man SM, Karki R, Malireddi RK, et al. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol. 2015;16(5):467–475. doi:10.1038/ni.3118
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood. 2008;112(5):1794–1803. doi:10.1182/blood-2008-01-134932
   PubMed Web of Science ®Google Scholar
• Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I. The pyrin inflammasome in health and disease. Front Immunol. 2019;10:1745. doi:10.3389/fimmu.2019.01745
   PubMed Web of Science ®Google Scholar
• La Bella S, Di Ludovico A, Di Donato G, et al. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases. Front Immunol. 2023;14:1341680. doi:10.3389/fimmu.2023.1341680
   PubMed Web of Science ®Google Scholar
• Magnotti F, Chirita D, Dalmon S, et al. Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism. Cell Rep. 2022;41(2):111472. doi:10.1016/j.celrep.2022.111472
   PubMed Web of Science ®Google Scholar
• Lau R, Hann MM, Ottmann C. Crystal structure and ligandability of the 14-3-3/pyrin interface. Biochem Biophys Res Commun. 2023;651:1–7. doi:10.1016/j.bbrc.2023.02.013
   PubMedGoogle Scholar
• Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(8):588–606. doi:10.1038/nrd.2018.97
   PubMed Web of Science ®Google Scholar
• Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411. doi:10.1038/nri3452
   PubMed Web of Science ®Google Scholar
• Xia CY, Guo YX, Lian WW, et al. The NLRP3 inflammasome in depression: potential mechanisms and therapies. Pharmacol Res. 2023;187:106625. doi:10.1016/j.phrs.2022.106625
   PubMed Web of Science ®Google Scholar
• Rashidi M, Wicks IP, Vince JE. Inflammasomes and cell death: common pathways in microparticle diseases. Trends Mol Med. 2020;26(11):1003–1020. doi:10.1016/j.molmed.2020.06.005
   PubMed Web of Science ®Google Scholar
• Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420. doi:10.1038/nri.2016.58
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002
   PubMed Web of Science ®Google Scholar
• Zheng X, Wan J, Tan G. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy. Front Immunol. 2023;14:1151185. doi:10.3389/fimmu.2023.1151185
   PubMed Web of Science ®Google Scholar
• Gritsenko A, Yu S, Martin-Sanchez F, et al. Priming is dispensable for NLRP3 inflammasome activation in human monocytes in vitro. Front Immunol. 2020;11:565924. doi:10.3389/fimmu.2020.565924
   PubMed Web of Science ®Google Scholar
• Kodi T, Sankhe R, Gopinathan A, Nandakumar K, Kishore A. New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation. J Neuroimmune Pharmacol. 2024;19(1):7. doi:10.1007/s11481-024-10101-5
   PubMed Web of Science ®Google Scholar
• Song N, Li T. Regulation of NLRP3 inflammasome by phosphorylation. Front Immunol. 2018;9:2305. doi:10.3389/fimmu.2018.02305
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo L, Xu X, et al. Acetylation is required for full activation of the NLRP3 inflammasome. Nat Commun. 2023;14(1):8396. doi:10.1038/s41467-023-44203-0
   PubMed Web of Science ®Google Scholar
• Xia J, Jiang S, Dong S, Liao Y, Zhou Y. The role of post-translational modifications in regulation of NLRP3 inflammasome activation. Int J Mol Sci. 2023;24(7):6126. doi:10.3390/ijms24076126
   PubMed Web of Science ®Google Scholar
• Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114–2127. doi:10.1038/s41423-021-00740-6
   PubMed Web of Science ®Google Scholar
• Qiang R, Li Y, Dai X, Lv W. NLRP3 inflammasome in digestive diseases: from mechanism to therapy. Front Immunol. 2022;13:978190. doi:10.3389/fimmu.2022.978190
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Shi H, Wang Y, Li X, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17(3):250–258. doi:10.1038/ni.3333
   PubMed Web of Science ®Google Scholar
• Yue Z, Zhang X, Gu Y, et al. Regulation and functions of the NLRP3 inflammasome in RNA virus infection. Front Cell Infect Microbiol. 2023;13:1309128. doi:10.3389/fcimb.2023.1309128
   PubMed Web of Science ®Google Scholar
• He XF, Li LL, Xian WB, et al. Chronic colitis exacerbates NLRP3-dependent neuroinflammation and cognitive impairment in middle-aged brain. J Neuroinflammation. 2021;18(1):153. doi:10.1186/s12974-021-02199-8
   PubMed Web of Science ®Google Scholar
• Bai B, Yang Y, Wang Q, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11(9):776. doi:10.1038/s41419-020-02985-x
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang Q, Lv C, et al. NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation. Cell Proliferation. 2021;54(2):e12973. doi:10.1111/cpr.12973
   PubMed Web of Science ®Google Scholar
• Jiang N, An J, Yang K, et al. NLRP3 inflammasome: a new target for prevention and control of osteoporosis? Front Endocrinol. 2021;12:752546. doi:10.3389/fendo.2021.752546
   PubMed Web of Science ®Google Scholar
• Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009;25(1):629–648. doi:10.1146/annurev.cellbio.042308.113308
   PubMedGoogle Scholar
• Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073. doi:10.3390/cells9092073
   PubMed Web of Science ®Google Scholar
• Hu K, Olsen BR. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest. 2016;126(2):509–526. doi:10.1172/JCI82585
   PubMed Web of Science ®Google Scholar
• Wagley Y, Chesi A, Acevedo PK, et al. Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation. Stem Cells. 2020;38(10):1332–1347. doi:10.1002/stem.3245
   PubMed Web of Science ®Google Scholar
• Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;423(6937):349–355. doi:10.1038/nature01660
   PubMed Web of Science ®Google Scholar
• Komori T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int J Mol Sci. 2019;20(7):1694. doi:10.3390/ijms20071694
   PubMed Web of Science ®Google Scholar
• Liu SC, Sun QZ, Qiao XF, et al. LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(11):4584–4590. doi:10.26355/eurrev_201906_18035
   PubMed Web of Science ®Google Scholar
• Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36(3):401–414. doi:10.1016/j.immuni.2012.01.009
   PubMed Web of Science ®Google Scholar
• Xian H, Watari K, Sanchez-Lopez E, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55(8):1370–1385.e1378. doi:10.1016/j.immuni.2022.06.007
   PubMed Web of Science ®Google Scholar
• Sun D, Peng Y, Ge S, Fu Q. USP1 Inhibits NF-κB/NLRP3 induced pyroptosis through TRAF6 in osteoblastic MC3T3-E1 cells. J Musculoskelet Neuronal Interact. 2022;22(4):536–545.
   PubMed Web of Science ®Google Scholar
• Liu S, Du J, Li D, et al. Oxidative stress induced pyroptosis leads to osteogenic dysfunction of MG63 cells. J Mol Histol. 2020;51(3):221–232. doi:10.1007/s10735-020-09874-9
   PubMed Web of Science ®Google Scholar
• Lei L, Sun J, Han J, Jiang X, Wang Z, Chen L. Interleukin-17 induces pyroptosis in osteoblasts through the NLRP3 inflammasome pathway in vitro. Int Immunopharmacol. 2021;96:107781. doi:10.1016/j.intimp.2021.107781
   PubMed Web of Science ®Google Scholar
• Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23(11):576–581. doi:10.1016/j.tem.2012.03.008
   PubMed Web of Science ®Google Scholar
• Liang S, Nian Z, Shi K. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways. Biochem Biophys Res Commun. 2020;526(4):1028–1035. doi:10.1016/j.bbrc.2020.03.177
   PubMed Web of Science ®Google Scholar
• Sasso G, Cerri PS, Sasso-Cerri E, Simões MJ, Gil CD, Florencio-Silva R. Possible role of annexin A1/FPR2 pathway in COX2/NLRP3 inflammasome regulation in alveolar bone cells of estrogen-deficient female rats with diabetes mellitus. J Periodontol. 2023. doi:10.1002/JPER.23-0530
   PubMed Web of Science ®Google Scholar
• Guo L, Zhang Y, Liu H, Cheng Q, Yang S, Yang D. All-trans retinoic acid inhibits the osteogenesis of periodontal ligament stem cells by promoting IL-1β production via NF-κB signaling. Int Immunopharmacol. 2022;108:108757. doi:10.1016/j.intimp.2022.108757
   PubMed Web of Science ®Google Scholar
• McCall SH, Sahraei M, Young AB, et al. Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death. J Bone Miner Res. 2008;23(1):30–40. doi:10.1359/jbmr.071002
   PubMed Web of Science ®Google Scholar
• Zhao P, Liu J, Pan C, Pan Y. NLRP3 inflammasome is required for apoptosis of Aggregatibacter actinomycetemcomitans-infected human osteoblastic MG63 cells. Acta Histochem. 2014;116(7):1119–1124. doi:10.1016/j.acthis.2014.05.008
   PubMed Web of Science ®Google Scholar
• Ran S, Chu M, Gu S, Wang J, Liang J. Enterococcus faecalis induces apoptosis and pyroptosis of human osteoblastic MG63 cells via the NLRP3 inflammasome. Int Endodontic J. 2019;52(1):44–53. doi:10.1111/iej.12965
   PubMed Web of Science ®Google Scholar
• Yoshida K, Okamura H, Hiroshima Y, et al. PKR induces the expression of NLRP3 by regulating the NF-κB pathway in Porphyromonas gingivalis-infected osteoblasts. Exp Cell Res. 2017;354(1):57–64. doi:10.1016/j.yexcr.2017.03.028
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhang K, Lu K, et al. Inhibition of pyroptosis attenuates Staphylococcus aureus-induced bone injury in traumatic osteomyelitis. Ann Translat Med. 2019;7(8):170. doi:10.21037/atm.2019.03.40
   PubMed Web of Science ®Google Scholar
• Dai W, Wang M, Wang P, et al. lncRNA NEAT1 ameliorates LPS‑induced inflammation in MG63 cells by activating autophagy and suppressing the NLRP3 inflammasome. IntJ Mol Med. 2021;47(2):607–620. doi:10.3892/ijmm.2020.4827
   PubMed Web of Science ®Google Scholar
• Yang Y, Miao L, Chang S, et al. Exosome-derived LncRNA TCONS_00072128 mediated osteogenic differentiation and inflammation by Caspase 8 regulation. Front Genetics. 2021;12:831420. doi:10.3389/fgene.2021.831420
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhao W, Chen Y, et al. RelA/MicroRNA-30a/NLRP3 signal axis is involved in rheumatoid arthritis via regulating NLRP3 inflammasome in macrophages. Cell Death Dis. 2021;12(11):1060. doi:10.1038/s41419-021-04349-5
   PubMed Web of Science ®Google Scholar
• Crivaro A, Bondar C, Mucci JM, et al. Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis. Mol Gene Metabol. 2020;130(4):274–282. doi:10.1016/j.ymgme.2020.06.003
   PubMed Web of Science ®Google Scholar
• Xu L, Shen L, Yu X, Li P, Wang Q, Li C. Effects of irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 inflammasome. Exp Ther Med. 2020;19(2):1084–1090. doi:10.3892/etm.2019.8313
   PubMed Web of Science ®Google Scholar
• Zhao W, Cao Y, Chen Y, et al. NLRP3 regulates mandibular healing through interaction with UCHL5 in MSCs. Int J Bio Sci. 2023;19(3):936–949. doi:10.7150/ijbs.78174
   Google Scholar
• Zhang J, Wei K. Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3/caspase-1/GSDMD pathway. Exp Cell Res. 2021;405(2):112648. doi:10.1016/j.yexcr.2021.112648
   PubMed Web of Science ®Google Scholar
• Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Bio Sci. 2012;8(2):272–288. doi:10.7150/ijbs.2929
   Google Scholar
• Li K, Han J, Wang Z. Histone modifications centric-regulation in osteogenic differentiation. Cell Death Discovery. 2021;7(1):91. doi:10.1038/s41420-021-00472-6
   PubMed Web of Science ®Google Scholar
• Guo J, Wang F, Hu Y, et al. Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Rep Med. 2023;4(1):100881. doi:10.1016/j.xcrm.2022.100881
   PubMedGoogle Scholar
• Guo X, Wu Z. GABARAP ameliorates IL-1β-induced inflammatory responses and osteogenic differentiation in bone marrow-derived stromal cells by activating autophagy. Sci Rep. 2021;11(1):11561. doi:10.1038/s41598-021-90586-9
   PubMed Web of Science ®Google Scholar
• Xie Z, Yu W, Zheng G, et al. TNF-α-mediated m(6)A modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis. Nat Commun. 2021;12(1):5373. doi:10.1038/s41467-021-25710-4
   PubMed Web of Science ®Google Scholar
• Bonar SL, Brydges SD, Mueller JL, et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS One. 2012;7(4):e35979. doi:10.1371/journal.pone.0035979
   PubMed Web of Science ®Google Scholar
• Ahn JS, Seo Y, Oh SJ, et al. The activation of NLRP3 inflammasome potentiates the immunomodulatory abilities of mesenchymal stem cells in a murine colitis model. BMB Rep. 2020;53(6):329–334. doi:10.5483/BMBRep.2020.53.6.065
   PubMed Web of Science ®Google Scholar
• Yang C, Song B, Han L, Gao Z. Study on the mechanism of NLRP3 effect on the skeleton of de-ovalized mice. Biochem Biophys Rep. 2023;35:101496. doi:10.1016/j.bbrep.2023.101496
   PubMedGoogle Scholar
• Ding Z, Chen W, Wu H, et al. Integrative network fusion-based multi-omics study for biomarker identification and patient classification of rheumatoid arthritis. Chin Med. 2023;18(1):48. doi:10.1186/s13020-023-00750-8
   PubMed Web of Science ®Google Scholar
• Duan Y, Li H, Dong X, Geng Z, Xu X, Liu Y. VEGF mitigates bisphosphonate-induced apoptosis and differentiation inhibition of MC3T3-E1 cells. Exp Ther Med. 2022;23(2):130. doi:10.3892/etm.2021.11053
   PubMed Web of Science ®Google Scholar
• Xia C, Ou S, Yang Y, et al. ELP2-NLRP3-GSDMD/GSDME-mediated pyroptosis is induced by TNF-α in MC3T3-E1 cells during osteogenic differentiation. J Cell Mol Med. 2023;27(24):4093–4106. doi:10.1111/jcmm.17994
   PubMed Web of Science ®Google Scholar
• Fang M, Li B, Li X, Wang Y, Zhuang Y. MicroRNA-29b regulates pyroptosis involving calcific aortic valve disease through the STAT3/SOCS1 pathway. Int J Cardiol. 2023;371:319–328. doi:10.1016/j.ijcard.2022.08.029
   PubMed Web of Science ®Google Scholar
• Jun C, Jun L, Shiting L, Qiangguo G, Gang Z. 降钙素基因相关肽通过抑制Nod样受体蛋白3表达促进小鼠成骨细胞分化的研究 [Calcitonin gene-related peptide inhibits the expression of Nod-like receptor protein 3 to Dromote osteoblast differentiation in mouse osteoblasts in vitro]. Hua xi kou qiang yi xue za zhi. 2016;34(1):12–16. Chinese. doi:10.7518/hxkq.2016.01.003
   PubMedGoogle Scholar
• Zheng W, Meng Z, Zhu Z, et al. Metal-organic framework-based nanomaterials for regulation of the osteogenic microenvironment. Small;2024. e2310622. doi:10.1002/smll.202310622
   PubMed Web of Science ®Google Scholar
• Yang N, Liu Y. The role of the immune microenvironment in bone regeneration. Int J Med Sci. 2021;18(16):3697–3707. doi:10.7150/ijms.61080
   PubMed Web of Science ®Google Scholar
• Zhang F, Lv M, Wang S, et al. Ultrasound-triggered biomimetic ultrashort peptide nanofiber hydrogels promote bone regeneration by modulating macrophage and the osteogenic immune microenvironment. Bioact Mater. 2024;31:231–246. doi:10.1016/j.bioactmat.2023.08.008
   PubMed Web of Science ®Google Scholar
• Long J, Yao Z, Zhang W, et al. Regulation of osteoimmune microenvironment and osteogenesis by 3D-Printed PLAG/black phosphorus scaffolds for bone regeneration. Adv Sci. 2023;10(28):e2302539. doi:10.1002/advs.202302539
   Web of Science ®Google Scholar
• Bai L, Song P, Su J. Bioactive elements manipulate bone regeneration. Biomate Rransl. 2023;4(4):248–269. doi:10.12336/biomatertransl.2023.04.005
   PubMedGoogle Scholar
• Zhang Y, Yan M, Niu W, et al. Tricalcium phosphate particles promote pyroptotic death of calvaria osteocytes through the ROS/NLRP3/Caspase-1 signaling axis in amouse osteolysis model. Int Immunopharmacol. 2022;107:108699. doi:10.1016/j.intimp.2022.108699
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yan M, Shan W, et al. Bisphenol A induces pyroptotic cell death via ROS/NLRP3/Caspase-1 pathway in osteocytes MLO-Y4. Food Chem Toxicol. 2022;159:112772. doi:10.1016/j.fct.2021.112772
   PubMed Web of Science ®Google Scholar
• Yao Y, Cai X, Ren F, et al. The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases. Front Immunol. 2021;12:664871. doi:10.3389/fimmu.2021.664871
   PubMed Web of Science ®Google Scholar
• Wang Z, Luo W, Zhang G, et al. FoxO1 knockdown inhibits RANKL-induced osteoclastogenesis by blocking NLRP3 inflammasome activation. Oral Dis. 2023. doi:10.1111/odi.14800
   Web of Science ®Google Scholar
• An Y, Zhang H, Wang C, et al. Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019;33(11):12515–12527. doi:10.1096/fj.201802805RR
   PubMed Web of Science ®Google Scholar
• Yao L, Huang C, Dai J. Staphylococcus aureus enhances osteoclast differentiation and bone resorption by stimulating the NLRP3 inflammasome pathway. Mol Biol Rep. 2023;50(11):9395–9403. doi:10.1007/s11033-023-08900-9
   PubMedGoogle Scholar
• Alippe Y, Wang C, Ricci B, et al. Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation. Sci Rep. 2017;7(1):6630. doi:10.1038/s41598-017-07014-0
   PubMedGoogle Scholar
• Pieters BCH, Cappariello A, van den Bosch MHJ, van Lent P, Teti A, van de Loo FAJ. Macrophage-derived extracellular vesicles as carriers of alarmins and their potential involvement in bone homeostasis. Front Immunol. 2019;10:1901. doi:10.3389/fimmu.2019.01901
   PubMed Web of Science ®Google Scholar
• Dai B, Xu J, Li X, et al. Macrophages in epididymal adipose tissue secrete osteopontin to regulate bone homeostasis. Nat Commun. 2022;13(1):427. doi:10.1038/s41467-021-27683-w
   PubMed Web of Science ®Google Scholar
• Muñoz J, Akhavan NS, Mullins AP, Arjmandi BH. Macrophage Polarization and Osteoporosis: a Review. Nutrients. 2020;12(10):2999. doi:10.3390/nu12102999
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang Z, Sun X, et al. STAT3/Mitophagy axis coordinates macrophage NLRP3 inflammasome activation and inflammatory bone loss. J Bone Miner Res. 2023;38(2):335–353. doi:10.1002/jbmr.4756
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu Y, Guo L, et al. Exosomal Lnc NEAT1 from endothelial cells promote bone regeneration by regulating macrophage polarization via DDX3X/NLRP3 axis. J Nanobiotechnol. 2023;21(1):98. doi:10.1186/s12951-023-01855-w
   PubMed Web of Science ®Google Scholar
• Hou L, Ye Y, Gou H, et al. A20 inhibits periodontal bone resorption and NLRP3-mediated M1 macrophage polarization. Exp Cell Res. 2022;418(1):113264. doi:10.1016/j.yexcr.2022.113264
   PubMed Web of Science ®Google Scholar
• Ge G, Bai J, Wang Q, et al. Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway. Sci China Life Sci. 2022;65(3):588–603. doi:10.1007/s11427-020-1939-1
   PubMed Web of Science ®Google Scholar
• Yang L, Tao W, Xie C, et al. Interleukin-37 ameliorates periodontitis development by inhibiting NLRP3 inflammasome activation and modulating M1/M2 macrophage polarization. J Periodontal Res. 2024;59(1):128–139. doi:10.1111/jre.13196
   PubMed Web of Science ®Google Scholar
• Grim JC, Aguado BA, Vogt BJ, et al. Secreted factors from proinflammatory macrophages promote an osteoblast-like phenotype in valvular interstitial cells. Arteriosclerosis Thrombosis Vasc Biol. 2020;40(11):e296–e308. doi:10.1161/ATVBAHA.120.315261
   PubMed Web of Science ®Google Scholar
• Wang Z, Feng X, Zhang G, et al. Artesunate ameliorates ligature-induced periodontitis by attenuating NLRP3 inflammasome-mediated osteoclastogenesis and enhancing osteogenic differentiation. Int Immunopharmacol. 2023;123:110749. doi:10.1016/j.intimp.2023.110749
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang X, Zhong X, et al. Puerarin inhibits vascular calcification of uremic rats. Eur J Pharmacol. 2019;855:235–243. doi:10.1016/j.ejphar.2019.05.023
   PubMed Web of Science ®Google Scholar
• Wang C, Xia Y, Qu L, Liu Y, Liu X, Xu K. Cardamonin inhibits osteogenic differentiation of human valve interstitial cells and ameliorates aortic valve calcification via interfering in the NF-κB/NLRP3 inflammasome pathway. Food Funct. 2021;12(23):11808–11818. doi:10.1039/D1FO00813G
   PubMed Web of Science ®Google Scholar
• Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, et al. β boswellic acid blocks articular innate immune responses: an in silico and in vitro approach to traditional medicine. Antioxidants. 2023;12(2):371. doi:10.3390/antiox12020371
   Web of Science ®Google Scholar
• Kim EN, Nabende WY, Jeong H, Hahn D, Jeong GS. The marine-derived natural product epiloliolide isolated from sargassum horneri regulates NLRP3 via PKA/CREB, promoting proliferation and anti-inflammatory effects of human periodontal ligament cells. Mar Drugs. 2021;19(7):388. doi:10.3390/md19070388
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu W, Wang Y, et al. A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity. Clin transl med. 2020;10(8):e240. doi:10.1002/ctm2.240
   PubMed Web of Science ®Google Scholar
• Liu M, Li F, Huang Y, et al. Caffeic acid phenethyl ester ameliorates calcification by inhibiting activation of the AKT/NF-κB/NLRP3 inflammasome pathway in human aortic valve interstitial cells. Front Pharmacol. 2020;11:826. doi:10.3389/fphar.2020.00826
   PubMed Web of Science ®Google Scholar
• Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, et al. Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: preclinical and clinical evidence in osteoarthritis and gout. Br J Pharmacol. 2022;179(2):270–286. doi:10.1111/bph.15707
   PubMed Web of Science ®Google Scholar
• Franco-Trepat E, Guillán-Fresco M, Alonso-Pérez A, et al. Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells. Biomed Pharmacother. 2022;155:113671. doi:10.1016/j.biopha.2022.113671
   PubMed Web of Science ®Google Scholar
• Fu F, Luo H, Du Y, et al. AR/PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes-related osteoporosis by activating Nrf2/Keap1 pathway. J Cell Mol Med. 2023;27(22):3601–3613. doi:10.1111/jcmm.17928
   PubMed Web of Science ®Google Scholar
• Greene E, Flees J, Dhamad A, et al. Double-stranded RNA is a novel molecular target in osteomyelitis pathogenesis: a translational avian model for human bacterial chondronecrosis with osteomyelitis. Am J Pathol. 2019;189(10):2077–2089. doi:10.1016/j.ajpath.2019.06.013
   PubMed Web of Science ®Google Scholar
• Chen W, Tang P, Fan S, Jiang X. A novel inhibitor INF 39 promotes osteogenesis via blocking the NLRP3/IL-1β axis. Biomed Res Int. 2022;2022:7250578. doi:10.1155/2022/7250578
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu M, Wang X, et al. ALP inhibitors inhibit inflammatory responses and osteoblast differentiation in hVIC via AKT-ERK pathways. Alternat Therap Health Med. 2023;29(1):58–65.
   PubMed Web of Science ®Google Scholar
• Zeng XZ, Zhang YY, Yang Q, et al. Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca(2+)-NFATc1 signaling pathway. Acta Pharmacol Sin. 2020;41(2):229–236. doi:10.1038/s41401-019-0289-6
   PubMed Web of Science ®Google Scholar
• Ye Y, Chen A, Li L, et al. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 2022;102(6):1259–1275. doi:10.1016/j.kint.2022.07.034
   PubMed Web of Science ®Google Scholar
• Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspect Med. 2020;76:100889. doi:10.1016/j.mam.2020.100889
   PubMed Web of Science ®Google Scholar
• Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265(1):35–52. doi:10.1111/imr.12286
   PubMed Web of Science ®Google Scholar
• Takahashi M. NLRP3 inflammasome as a key driver of vascular disease. Cardiovasc Res. 2022;118(2):372–385. doi:10.1093/cvr/cvab010
   PubMed Web of Science ®Google Scholar
• Yang F, Qin Y, Wang Y, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Bio Sci. 2019;15(5):1010–1019. doi:10.7150/ijbs.29680
   Google Scholar
• Zhang Y, Yang W, Li W, Zhao Y. NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases. Front Immunol. 2021;12:732933. doi:10.3389/fimmu.2021.732933
   PubMed Web of Science ®Google Scholar
• Titorencu I, Pruna V, Jinga VV, Simionescu M. Osteoblast ontogeny and implications for bone pathology: an overview. Cell Tissue Res. 2014;355(1):23–33. doi:10.1007/s00441-013-1750-3
   PubMed Web of Science ®Google Scholar
• Jin X, Liu D, Zhou X, Luo X, Huang Q, Huang Y. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7. Cell Rep Med. 2023;4(12):101310. doi:10.1016/j.xcrm.2023.101310
   PubMedGoogle Scholar